Solvay SA Says to Pay 177.6M Euros for Innogenetics
BRUSSELS, April 25 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay said on Friday it was paying 177.6 million euros ($276.9 million) to take full control of Belgian biotech company Innogenetics.